March 17, 2025 · Form 4 insider transaction
Nunes Anne bought 3,637 shares of Anika Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Reflects the first vesting installment of RSUs granted on March 15, 2024, which the Company elected to settle in shares.